BRIEF published on 07/23/2024 at 17:57, 1 year 4 months ago GUERBET: Number of shares and voting rights as of June 30, 2024 Capital Actions AMF Guerbet Right To Vote
BRIEF published on 06/24/2024 at 12:06, 1 year 5 months ago GUERBET: Number of shares and voting rights as of May 31, 2024 Voting Rights Capital Actions AMF Guerbet
BRIEF published on 05/24/2024 at 17:50, 1 year 6 months ago Hugues Lecat Appointed Chairman of the Board of Directors at Guerbet AI Solutions Appointment Medical Imaging Hugues Lecat Guerbet Board
PRESS RELEASE published on 05/24/2024 at 17:45, 1 year 6 months ago Guerbet : Hugues Lecat appointed Chairman of the Board of Directors of Guerbet. Hugues Lecat appointed Chairman of the Board of Guerbet. Didier Izabel remains as a director. Strategic acceleration and innovative AI solutions in focus Guerbet Medical Imaging Chairman Of The Board Hugues Lecat Didier Izabel
BRIEF published on 05/21/2024 at 12:12, 1 year 6 months ago Number of Guerbet shares and voting rights as of April 30, 2024 Share Capital Voting Rights Actions Transparency Guerbet
BRIEF published on 03/20/2024 at 18:05, 1 year 8 months ago Important Changes to the Guerbet Board of Directors Board Of Directors Pharmaceutical Guerbet Medical Imaging Hugues Lecat
PRESS RELEASE published on 03/20/2024 at 18:00, 1 year 8 months ago Guerbet: Change in Guerbet’s Board of Directors. Guerbet appoints Hugues Lecat as a non-voting director with plans for him to become Chairman, enhancing the company's governance and strategic vision for future success Board Of Directors Guerbet Medical Imaging Chairman Appointment Hugues Lecat
BRIEF published on 03/20/2024 at 17:50, 1 year 8 months ago Guerbet Announces Solid Growth and Improved Profitability in 2023 Full-Year Results Financial Results Profitability Guerbet Healthcare Imaging 2023 Growth
PRESS RELEASE published on 03/20/2024 at 17:45, 1 year 8 months ago Guerbet: 2023 full-year results. Guerbet publishes solid 2023 full-year results with revenue growth of 5.9% at CER and EBITDA margin exceeding target. Confirms outlook for 2024 with revenue growth > 8% and higher profitability Revenue Growth 2024 Outlook EBITDA Margin Guerbet 2023 Full-year Results
BRIEF published on 03/11/2024 at 08:05, 1 year 8 months ago Guerbet announces key appointments to boost its long-term strategy Innovation Appointments Guerbet Medical Imaging Long-term Strategy
Published on 12/05/2025 at 02:35, 5 hours 15 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 50 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 45 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 50 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 50 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 4 hours 20 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 59 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 25 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 35 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:00, 13 hours 50 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 14 hours 5 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 14 hours 6 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025
